STRATA Skin Sciences (NASDAQ:SSKN) Issues Quarterly Earnings Results

STRATA Skin Sciences (NASDAQ:SSKN) posted its earnings results on Thursday. The medical device company reported ($1.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.73), Zacks reports. STRATA Skin Sciences had a negative net margin of 28.72% and a negative return on equity of 69.33%.

STRATA Skin Sciences Price Performance

NASDAQ:SSKN traded up $0.03 during trading hours on Thursday, hitting $2.64. 2,388 shares of the company’s stock traded hands, compared to its average volume of 12,188. STRATA Skin Sciences has a 52 week low of $2.51 and a 52 week high of $5.90. The business’s fifty day simple moving average is $2.76 and its two-hundred day simple moving average is $2.92. The company has a quick ratio of 0.94, a current ratio of 1.13 and a debt-to-equity ratio of 1.62. The firm has a market cap of $11.01 million, a P/E ratio of -0.99 and a beta of 1.32.

Analyst Upgrades and Downgrades

Separately, Maxim Group initiated coverage on shares of STRATA Skin Sciences in a research note on Thursday, February 27th. They set a “buy” rating and a $6.00 price objective for the company.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.